IQVIA Holdings Inc (IQV)

Over the past six months, IQVIA Holdings, Inc. stock has demonstrated strong performance, gaining 48% and outperforming its sector and the S&P 500 Index. In October 2025, IQVIA announced its third-quarter results for fiscal 2025, exceeding Wall Street analysts' expectations. In December 2025, IQVIA announced a strategic partnership with Amazon Web Services (AWS) to power its next-generation AI platform. Analysts have maintained a "Moderate Buy" or "Strong Buy" consensus rating for IQV, with several firms raising their price targets. In October 2025, insider Eric Sherbet sold 4,000 shares of IQVIA stock, while directors bought shares around January 2026. The stock reached a new 52-week high of $247.05 on January 9, 2026.

IQVIA's demand is influenced by factors within the biopharmaceutical and healthcare industries rather than traditional seasonal patterns. The company's commercial services can be affected by the timing of new drug launches and patent expirations. The biopharmaceutical and healthcare industries are subject to financial pressures and evolving regulations, which can lead to fluctuations in the demand for IQVIA's services.

IQVIA Holdings, Inc. is a global provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries. It operates within the medical research and healthcare sectors, offering services across the healthcare value chain. The company's major products and services are delivered through three core segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. IQVIA leverages health data, AI, analytics, and technology to support drug development, regulatory reporting, commercial strategy, and real-world evidence generation.

IQVIA Holdings, Inc. is headquartered in Durham, North Carolina, USA, and operates in over 100 countries across the Americas, Europe, Africa, and Asia-Pacific.

IQVIA has consistently maintained a strong brand reputation. IQVIA was named No. 1 in its category on the 2025 Fortune® World's Most Admired Companies™ list for the fourth consecutive year. The company achieved first place in its category for innovation, global competitiveness, people management, and use of corporate assets.

IQVIA Holdings, Inc. is predominantly owned by institutional investors, who collectively hold approximately 92.35% of the company's outstanding shares as of March 31, 2025. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and Harris Associates L.P. Key individual owners include Ari Bousbib (Chairman & CEO) and John M. Leonard (Lead Director).